US Stock MarketDetailed Quotes

Immix Biopharma (IMMX)

Watchlist
  • 10.420
  • -0.070-0.67%
Trading May 14 10:32 ET
566.97MMarket Cap-11.33P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Immix Biopharma (IMMX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
130.71%10.8M
32.11%29.96M
118.43%10.89M
3.62%7.66M
42.85%6.72M
-16.23%4.68M
40.48%22.67M
-7.23%4.99M
63.47%7.39M
26.39%4.7M
Selling and administrative expenses
78.13%4.82M
20.35%13.7M
43.00%5.17M
4.37%3.08M
10.77%2.75M
15.65%2.71M
53.68%11.38M
58.80%3.61M
21.99%2.95M
63.97%2.48M
-General and administrative expense
78.13%4.82M
20.35%13.7M
43.00%5.17M
4.37%3.08M
10.77%2.75M
15.65%2.71M
53.68%11.38M
58.80%3.61M
21.99%2.95M
63.97%2.48M
Research and development costs
202.80%5.98M
43.97%16.26M
316.70%5.73M
3.12%4.58M
78.61%3.97M
-39.20%1.98M
29.28%11.29M
-55.68%1.37M
111.09%4.45M
0.67%2.22M
Operating profit
-130.71%-10.8M
-32.11%-29.96M
-118.43%-10.89M
-3.62%-7.66M
-42.85%-6.72M
16.23%-4.68M
-40.48%-22.67M
7.23%-4.99M
-63.47%-7.39M
-26.39%-4.7M
Net non-operating interest income expense
377.41%717.17K
-45.40%555.53K
16.61%216.71K
-67.06%84.54K
-66.10%104.06K
-43.93%150.22K
77.86%1.02M
-18.69%185.85K
37.49%256.68K
138.20%306.92K
Non-operating interest income
377.41%717.17K
-45.40%555.53K
16.61%216.71K
-67.06%84.54K
-66.10%104.06K
-43.93%150.22K
77.86%1.02M
-18.69%185.85K
37.49%256.68K
138.20%306.92K
Other net income (expense)
Income before tax
-122.53%-10.09M
-35.75%-29.4M
-122.37%-10.68M
-6.16%-7.58M
-50.46%-6.61M
14.83%-4.53M
-39.10%-21.66M
6.72%-4.8M
-64.59%-7.14M
-22.38%-4.4M
Income tax
0
-8.07%37.72K
4.46%11.27K
-30.71%7.72K
-13.20%8.91K
11.12%9.82K
55.35%41.04K
33.33%10.79K
63.71%11.14K
61.74%10.27K
Net income
-122.05%-10.09M
-35.67%-29.44M
-122.11%-10.69M
-6.10%-7.59M
-50.31%-6.62M
14.79%-4.54M
-39.13%-21.7M
6.66%-4.81M
-64.58%-7.15M
-22.45%-4.41M
Net income continuous Operations
-122.05%-10.09M
-35.67%-29.44M
-122.11%-10.69M
-6.10%-7.59M
-50.31%-6.62M
14.79%-4.54M
-39.13%-21.7M
6.66%-4.81M
-64.58%-7.15M
-22.45%-4.41M
Minority interest income
0
0
0
0
0
49.85%-84.99K
0
0
41.29%-12.91K
Net income attributable to the parent company
-122.05%-10.09M
-36.21%-29.44M
-122.11%-10.69M
-6.10%-7.59M
-50.75%-6.62M
13.62%-4.54M
-40.11%-21.61M
5.45%-4.81M
-67.02%-7.15M
-22.84%-4.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-122.05%-10.09M
-36.21%-29.44M
-122.11%-10.69M
-6.10%-7.59M
-50.75%-6.62M
13.62%-4.54M
-40.11%-21.61M
5.45%-4.81M
-67.02%-7.15M
-22.84%-4.39M
Basic earnings per share
-20.00%-0.18
-17.11%-0.89
-75.00%-0.28
0.00%-0.24
-46.67%-0.22
31.82%-0.15
14.61%-0.76
33.33%-0.16
-4.35%-0.24
37.50%-0.15
Diluted earnings per share
-20.00%-0.18
-17.11%-0.89
-75.00%-0.28
0.00%-0.24
-46.67%-0.22
31.82%-0.15
14.61%-0.76
33.33%-0.16
-4.35%-0.24
37.50%-0.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 130.71%10.8M32.11%29.96M118.43%10.89M3.62%7.66M42.85%6.72M-16.23%4.68M40.48%22.67M-7.23%4.99M63.47%7.39M26.39%4.7M
Selling and administrative expenses 78.13%4.82M20.35%13.7M43.00%5.17M4.37%3.08M10.77%2.75M15.65%2.71M53.68%11.38M58.80%3.61M21.99%2.95M63.97%2.48M
-General and administrative expense 78.13%4.82M20.35%13.7M43.00%5.17M4.37%3.08M10.77%2.75M15.65%2.71M53.68%11.38M58.80%3.61M21.99%2.95M63.97%2.48M
Research and development costs 202.80%5.98M43.97%16.26M316.70%5.73M3.12%4.58M78.61%3.97M-39.20%1.98M29.28%11.29M-55.68%1.37M111.09%4.45M0.67%2.22M
Operating profit -130.71%-10.8M-32.11%-29.96M-118.43%-10.89M-3.62%-7.66M-42.85%-6.72M16.23%-4.68M-40.48%-22.67M7.23%-4.99M-63.47%-7.39M-26.39%-4.7M
Net non-operating interest income expense 377.41%717.17K-45.40%555.53K16.61%216.71K-67.06%84.54K-66.10%104.06K-43.93%150.22K77.86%1.02M-18.69%185.85K37.49%256.68K138.20%306.92K
Non-operating interest income 377.41%717.17K-45.40%555.53K16.61%216.71K-67.06%84.54K-66.10%104.06K-43.93%150.22K77.86%1.02M-18.69%185.85K37.49%256.68K138.20%306.92K
Other net income (expense)
Income before tax -122.53%-10.09M-35.75%-29.4M-122.37%-10.68M-6.16%-7.58M-50.46%-6.61M14.83%-4.53M-39.10%-21.66M6.72%-4.8M-64.59%-7.14M-22.38%-4.4M
Income tax 0-8.07%37.72K4.46%11.27K-30.71%7.72K-13.20%8.91K11.12%9.82K55.35%41.04K33.33%10.79K63.71%11.14K61.74%10.27K
Net income -122.05%-10.09M-35.67%-29.44M-122.11%-10.69M-6.10%-7.59M-50.31%-6.62M14.79%-4.54M-39.13%-21.7M6.66%-4.81M-64.58%-7.15M-22.45%-4.41M
Net income continuous Operations -122.05%-10.09M-35.67%-29.44M-122.11%-10.69M-6.10%-7.59M-50.31%-6.62M14.79%-4.54M-39.13%-21.7M6.66%-4.81M-64.58%-7.15M-22.45%-4.41M
Minority interest income 0000049.85%-84.99K0041.29%-12.91K
Net income attributable to the parent company -122.05%-10.09M-36.21%-29.44M-122.11%-10.69M-6.10%-7.59M-50.75%-6.62M13.62%-4.54M-40.11%-21.61M5.45%-4.81M-67.02%-7.15M-22.84%-4.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -122.05%-10.09M-36.21%-29.44M-122.11%-10.69M-6.10%-7.59M-50.75%-6.62M13.62%-4.54M-40.11%-21.61M5.45%-4.81M-67.02%-7.15M-22.84%-4.39M
Basic earnings per share -20.00%-0.18-17.11%-0.89-75.00%-0.280.00%-0.24-46.67%-0.2231.82%-0.1514.61%-0.7633.33%-0.16-4.35%-0.2437.50%-0.15
Diluted earnings per share -20.00%-0.18-17.11%-0.89-75.00%-0.280.00%-0.24-46.67%-0.2231.82%-0.1514.61%-0.7633.33%-0.16-4.35%-0.2437.50%-0.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.20%
Sample Name
Sample Code
 +14.85%
Sample Name
Sample Code
 +13.77%
4
United States Oil Fund LP
USO
+13.09%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+10.80%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.14%
Sample Name
Sample Code
 +10.13%
Sample Name
Sample Code
 +9.69%
4
Hesai
HSAI
+6.88%
5
NIO Inc
NIO
+6.56%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -